# Anti-mullerian Hormone,Testesterone,Esrtadiol,Testesterone/Esrtadiol Ratio as Predictive Values for TESA and TESE Outcome in Non Obstructive Azoospermia

> **NCT04308486** · — · UNKNOWN · sponsor: **Assiut University** · enrollment: 50 (estimated)

## Conditions studied

- Non-obstructive Azoospermia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04308486
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12
- **Primary completion:** 2021-12
- **Final completion:** 2022-02
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2020-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04308486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04308486, "Anti-mullerian Hormone,Testesterone,Esrtadiol,Testesterone/Esrtadiol Ratio as Predictive Values for TESA and TESE Outcome in Non Obstructive Azoospermia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04308486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
